MedPath

Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong Province

Completed
Conditions
Helicobacter Pylori Infection
Registration Number
NCT04918134
Lead Sponsor
Shandong University
Brief Summary

Helicobacter pylori can lead to a variety of digestive system diseases.The eradication of Helicobacter pylori plays an importment role for the treatment of gastrointestinal ulcer and prevention of gastric cancer .Compared with other countries and regions in the world, the infection rate of Helicobacter pylori in China can reach more than 50%. The non-standard diagnosis and treatment of Helicobacter pylori greatly reduces its eradication rate and increases its drug resistance.Therefore, it is very important to strengthen the standardization of diagnosis and treatment to improve the eradication rate.

The purpose of this study is to investigate the diagnosis and treatment status of Helicobacter pylori among gastroenterologists in general hospitals in Shandong Province.It can help us to understand the actual situation of diagnosis and treatment of Helicobacter pylori in hospitals at all levels, and to provide targeted diagnosis and treatment training for doctors.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • All the gastroenterologists in secondary and tertiary general hospitals of Shandong province
Exclusion Criteria
  • A hospital that does not include gastroenterology
  • Hospitals and gastroenterologists that refuse to sign informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the results of the questionnaires2 months

the results of each question of the questionnaires

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Qilu hosipital

🇨🇳

Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath